Atria Investments Lifted Its Cvs Health (CVS) Position; Pennsylvania Trust Co Upped Abbvie (ABBV) Holding

November 5, 2017 - By Clifton Ray

Atria Investments Llc increased Cvs Health Corp (CVS) stake by 14.79% reported in 2017Q2 SEC filing. Atria Investments Llc acquired 4,372 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Atria Investments Llc holds 33,935 shares with $2.73 million value, up from 29,563 last quarter. Cvs Health Corp now has $70.40 billion valuation. The stock decreased 0.19% or $0.13 on November 3, reaching $69.25. About 9.90M shares traded or 17.86% up from the average. CVS Health Corp (NYSE:CVS) has declined 24.40% since November 5, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Pennsylvania Trust Co increased Abbvie Inc (ABBV) stake by 126.6% reported in 2017Q2 SEC filing. Pennsylvania Trust Co acquired 136,876 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Pennsylvania Trust Co holds 244,995 shares with $17.77 million value, up from 108,119 last quarter. Abbvie Inc now has $147.15 billion valuation. The stock increased 1.42% or $1.29 on November 3, reaching $92.31. About 3.62M shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since November 5, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Investors sentiment increased to 1 in 2017 Q2. Its up 0.01, from 0.99 in 2017Q1. It is positive, as 55 investors sold ABBV shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. 1.04 billion shares or 0.53% more from 1.04 billion shares in 2017Q1 were reported. Walter Keenan Fin Consulting Com Mi Adv owns 34,366 shares or 1.25% of their US portfolio. Girard Prtn Ltd stated it has 13,665 shares or 0.21% of all its holdings. E&G Advsrs Ltd Partnership owns 5,700 shares for 0.2% of their portfolio. Mrj Cap reported 43,400 shares. Santa Barbara Asset Mgmt Ltd reported 2.70 million shares. Janney Montgomery Scott Lc has invested 0.49% in AbbVie Inc (NYSE:ABBV). Montag A And has invested 0.57% in AbbVie Inc (NYSE:ABBV). Conning reported 53,134 shares stake. Caisse De Depot Et Placement Du Quebec has 0.09% invested in AbbVie Inc (NYSE:ABBV). Quantitative Investment Mgmt Ltd Llc holds 0.82% or 750,800 shares in its portfolio. Davidson Investment Advsrs holds 0.1% in AbbVie Inc (NYSE:ABBV) or 9,745 shares. Ellington Mgmt Group Inc Llc, a Connecticut-based fund reported 5,800 shares. Fjarde Ap holds 0.53% or 362,165 shares. Calamos Ltd Liability Com reported 0.11% in AbbVie Inc (NYSE:ABBV). Somerville Kurt F reported 30,350 shares.

Pennsylvania Trust Co decreased Vanguard Index Fds (VNQ) stake by 19,549 shares to 32,341 valued at $2.69 million in 2017Q2. It also reduced Target Corp (NYSE:TGT) stake by 23,743 shares and now owns 24,793 shares. Sysco Corp (NYSE:SYY) was reduced too.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 66 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained AbbVie Inc (NYSE:ABBV) on Thursday, May 25 with “Buy” rating. BMO Capital Markets maintained the shares of ABBV in report on Wednesday, April 19 with “Hold” rating. The stock of AbbVie Inc (NYSE:ABBV) earned “Buy” rating by SunTrust on Wednesday, July 22. The firm has “Hold” rating by Credit Suisse given on Thursday, July 20. The firm has “Hold” rating given on Sunday, July 30 by BMO Capital Markets. BMO Capital Markets maintained the stock with “Hold” rating in Friday, April 28 report. UBS maintained the shares of ABBV in report on Friday, October 23 with “Buy” rating. The company was initiated on Friday, September 2 by Raymond James. The rating was downgraded by Goldman Sachs to “Buy” on Monday, March 7. Jefferies maintained it with “Buy” rating and $94 target in Monday, July 17 report.

Since May 4, 2017, it had 0 insider buys, and 4 sales for $15.96 million activity. 79,800 shares were sold by Schumacher Laura J, worth $5.59 million. ALBAN CARLOS sold $3.21 million worth of AbbVie Inc (NYSE:ABBV) on Wednesday, June 14. CHASE WILLIAM J also sold $2.50 million worth of AbbVie Inc (NYSE:ABBV) on Thursday, May 18. $4.67M worth of stock was sold by GONZALEZ RICHARD A on Friday, May 19.

Since June 12, 2017, it had 0 insider buys, and 1 insider sale for $18.44 million activity. $18.44M worth of stock was sold by Denton David M on Monday, June 12.

Atria Investments Llc decreased Select Sector Spdr Tr (XLF) stake by 17,381 shares to 77,426 valued at $1.91M in 2017Q2. It also reduced Spdr S&P 500 Etf Tr (SPY) stake by 40,555 shares and now owns 283,109 shares. Ishares Tr (TIP) was reduced too.

Investors sentiment decreased to 0.92 in 2017 Q2. Its down 0.17, from 1.09 in 2017Q1. It worsened, as 84 investors sold CVS shares while 559 reduced holdings. 108 funds opened positions while 483 raised stakes. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. Veritas Investment Mngmt (Uk) holds 185,104 shares. Groesbeck Investment Mgmt Nj invested 0.92% of its portfolio in CVS Health Corp (NYSE:CVS). Riverhead Cap Lc accumulated 97,791 shares. Regions accumulated 0.3% or 320,613 shares. 523,973 are owned by Johnson Invest Counsel. Puzo Michael J accumulated 2.96% or 68,285 shares. 16,678 were accumulated by Eads Heald Counsel. Rhenman And Asset Mngmt owns 85,000 shares or 0.98% of their US portfolio. Point72 Asia (Hong Kong) stated it has 0.01% of its portfolio in CVS Health Corp (NYSE:CVS). Fjarde Ap holds 0.38% or 235,241 shares. 77,520 were accumulated by Bush Odonnell Investment Advsr. Fishman Jay A Limited Mi owns 22,199 shares. Andra Ap reported 0.21% stake. Massmutual Tru Fsb Adv stated it has 0% in CVS Health Corp (NYSE:CVS). West Oak Cap Ltd stated it has 19,670 shares or 0% of all its holdings.